Replies to post #30820 on CV Sciences Inc (CVSI)

[CashMoneyCarl]

Chances are (if u look at the % of drugs that do clinical trials vs how many get FDA approval) it will fail and the cost will be in the multi-millions = debt and profit drain.

The flip side of this is the appeal for the patent fails and CVSI is denied (for real) a patent at all. That might mean that the 007 drug is put on the back burner, which would mean no clinical trials and no debt. So in a way it could work out because no debt is still a good thing.

[SweetEquity]

I'm would think a patented formulation with CBD, assuming the other components are not novel compounds, would not go through the very expensive and long NDA approval process. I would think it would go through the abbreviated 505 (b)(2) process. Key features of 505(b)(2)Drug Approval Pathway and Getting Cannabis Related Products Approved: The 505(b)(2) Projects

[ap17]

Agreed! That would be the ultimate move capital wise.

[baldingcontrarian]

Yes as stated months ago

That s my number one concern-they go it alone

It would make no sense fr them to do that

We are a CBD marketer
Not a pharma

Costs would be stupid